Effects of Calcium-Entry Antagonists in Hypertension
- 1 January 1982
- journal article
- Published by Taylor & Francis in Clinical and Experimental Hypertension. Part A: Theory and Practice
- Vol. 4 (1-2) , 271-284
- https://doi.org/10.3109/10641968209061590
Abstract
(1982). Effects of Calcium-Entry Antagonists in Hypertension. Clinical and Experimental Hypertension. Part A: Theory and Practice: Vol. 4, No. 1-2, pp. 271-284.Keywords
This publication has 32 references indexed in Scilit:
- Leucocyte cation transport in essential hypertension: its relation to the renin-angiotensin system.BMJ, 1981
- Verapamil in the Treatment of HypertensionJournal of Cardiovascular Pharmacology, 1981
- Commentary: What is the Link Between Vascular Smooth Muscle Sodium Pumps and Hypertension?Clinical and Experimental Hypertension, 1981
- Intralymphocytic Sodium in Hypertensive Patients: A Significant CorrelationClinical Science, 1979
- Antihypertensive effect of cardiovascular Ca2+-antagonist in hypertensive patients in the absence and presence of beta-adrenergic blockadeAmerican Heart Journal, 1978
- Sodium ions, calcium ions, blood pressure regulation, and hypertension: a reassessment and a hypothesisAmerican Journal of Physiology-Cell Physiology, 1977
- Hypotensive Action and Increased Plasma Renin Activity by Ca2+ Antagonist (Nifedipine) in Hypertensive PatientsJapanese Heart Journal, 1976
- The interrelationship between sodium and calcium fluxes across cell membranesPublished by Springer Nature ,1973
- Klinisch-experimentelle Untersuchungen über die blutdrucksenkende Wirkung von VerapamilDeutsche Medizinische Wochenschrift (1946), 1970
- Iproveratril als Antihypertonikum bei krisenhafter renaler HypertonieDeutsche Medizinische Wochenschrift (1946), 1969